ECF 2020 Highlights Podcast

 

Dr Rachel Giles guides us through 6 abstracts from the European Charcot Foundation 28th Annual Meeting:

1. No association between Ig levels and infection in ofatumumab-treated patients - Wiendl et al.
2. First long-term efficacy data of a BTK inhibitor - Montalban et al.
3. Reliable and convenient method to assess cognitive function in MS patients - Miyazaki et al.
4. Real-world efficacy of ocrelizumab in MS patients - Eggebrecht et al.
5. Long-term safety and efficacy of ozanimod in relapsing MS - Selmaj et al.
6. Superior effect of ponesimod versus teriflunomide on clinical disease activity and MRI-based outcomes - Kappos et al.

Posted on 16 December, 202028 January, 2021